Montauk Renewables, Inc. (NASDAQ:MNTK – Get Free Report) has earned an average recommendation of “Reduce” from the five analysts that are presently covering the firm, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell recommendation and four have assigned a hold recommendation to the company. The average 1-year price target among analysts that have issued a report on the stock in the last year is $1.80.
MNTK has been the subject of a number of recent research reports. Scotiabank dropped their price objective on Montauk Renewables from $4.00 to $2.00 and set a “sector perform” rating for the company in a research report on Wednesday, April 22nd. UBS Group lowered their price target on Montauk Renewables from $2.85 to $1.60 and set a “neutral” rating for the company in a report on Friday, April 24th. Zacks Research cut Montauk Renewables from a “strong-buy” rating to a “hold” rating in a report on Thursday, May 14th. Weiss Ratings restated a “sell (d)” rating on shares of Montauk Renewables in a report on Tuesday, April 21st. Finally, Wall Street Zen upgraded Montauk Renewables from a “sell” rating to a “hold” rating in a report on Saturday, March 7th.
Read Our Latest Research Report on Montauk Renewables
Montauk Renewables Trading Up 1.3%
Montauk Renewables (NASDAQ:MNTK – Get Free Report) last posted its quarterly earnings data on Wednesday, March 11th. The company reported $0.02 EPS for the quarter, missing analysts’ consensus estimates of $0.06 by ($0.04). The company had revenue of $43.39 million for the quarter, compared to analysts’ expectations of $44.39 million. Montauk Renewables had a return on equity of 0.28% and a net margin of 0.40%. Equities research analysts predict that Montauk Renewables will post 0.08 earnings per share for the current fiscal year.
Institutional Trading of Montauk Renewables
Several hedge funds and other institutional investors have recently added to or reduced their stakes in MNTK. Citadel Advisors LLC grew its holdings in Montauk Renewables by 178.4% in the 3rd quarter. Citadel Advisors LLC now owns 204,707 shares of the company’s stock valued at $411,000 after buying an additional 131,164 shares during the period. JPMorgan Chase & Co. grew its holdings in Montauk Renewables by 174.6% in the 3rd quarter. JPMorgan Chase & Co. now owns 177,855 shares of the company’s stock valued at $357,000 after buying an additional 113,083 shares during the period. J. Derek Lewis & Associates Inc. purchased a new stake in Montauk Renewables in the 1st quarter valued at about $98,000. Jane Street Group LLC grew its holdings in Montauk Renewables by 303.4% in the 1st quarter. Jane Street Group LLC now owns 100,834 shares of the company’s stock valued at $213,000 after buying an additional 75,836 shares during the period. Finally, Deutsche Bank AG grew its holdings in Montauk Renewables by 20,885.3% in the 4th quarter. Deutsche Bank AG now owns 47,007 shares of the company’s stock valued at $79,000 after buying an additional 46,783 shares during the period. Hedge funds and other institutional investors own 16.35% of the company’s stock.
Montauk Renewables Company Profile
Montauk Renewables Holdings, Inc is a renewable energy company headquartered in Irving, Texas, specializing in the capture and conversion of landfill gas into clean energy products. The company’s core operations focus on the design, development and operation of landfill gas collection systems that extract methane and other biogases generated by municipal solid waste. Montauk processes this gas into renewable natural gas (RNG) suitable for pipeline injection and also generates electricity for sale to utilities and commercial consumers.
Through its subsidiaries, Montauk provides a suite of environmental and waste‐management services across the United States and Canada.
Read More
- Five stocks we like better than Montauk Renewables
- Workday Validates AI Flywheel: Stock Price Recovery Begins
- HubSpot at 2019 Levels Is an Opportunity—Not a Warning
- Was Decker’s Double Beat a Bullish Signal—Or Mere HOKA’s-Pocus?
- Kiniksa Pharmaceuticals Still Has Room to Run After 100% Rally
Receive News & Ratings for Montauk Renewables Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Montauk Renewables and related companies with MarketBeat.com's FREE daily email newsletter.
